The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity

Gastroenterology

Volumn 145, Issue 5, 2013, Pages 1026-1034

  Werner, Jens M ^a   Abdalla, Adil ^a   Gara, Naveen ^a   Ghany, Marc G ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Immune Response; Immunization; T Cell; Virus

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPTAVAX; RECOMBINANT HEPATITIS B VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; T LYMPHOCYTE; VACCINATION;

EID: 84886775045     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.07.044     Document Type: Article

References (21)

1. M. Dandri, and S. Locarnini New insight in the pathobiology of hepatitis B virus infection Gut 61 Suppl 1 2012 i6 i17
2. C.E. Stevens, P.E. Taylor, and M.J. Tong Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257 1987 2612 2616
3. W. Szmuness, C.E. Stevens, and E.J. Harley Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection N Engl J Med 307 1982 1481 1486
4. J.W. Gold, J.W. Shih, and R.H. Purcell Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants J Immunol 117 1976 1404 1406
5. C. Venters, W. Graham, and W. Cassidy Recombivax-HB: perspectives past, present and future Expert Rev Vaccines 3 2004 119 129
6. W. Jilg, M. Schmidt, and F. Deinhardt Vaccination against hepatitis B: comparison of three different vaccination schedules J Infect Dis 160 1989 766 769
7. W. Jilg, M. Schmidt, and F. Deinhardt Decline of anti-HBs after hepatitis B vaccination and timing of revaccination Lancet 335 1990 173 174
8. B.J. McMahon, D.L. Bruden, and K.M. Petersen Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up Ann Intern Med 142 2005 333 341
9. A.R. Zanetti, A. Mariano, and L. Romano Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study Lancet 366 2005 1379 1384
10. C.Y. Lu, B.L. Chiang, and W.K. Chi Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination Hepatology 40 2004 1415 1420
11. I.T. Williams, S.T. Goldstein, and J. Tufa Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination Pediatr Infect Dis J 22 2003 157 163
12. C.Y. Lu, Y.H. Ni, and B.L. Chiang Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization J Infect Dis 197 2008 1419 1426
13. L.R. Bulkow, R.B. Wainwright, and B.J. McMahon Increases in levels of antibody to hepatitis B surface antigen in an immunized population Clin Infect Dis 26 1998 933 937
14. F. Rahman, T. Heller, and Y. Sobao Effects of antiviral therapy on the cellular immune response in acute hepatitis C Hepatology 40 2004 87 97
15. F. Galibert, E. Mandart, and F. Fitoussi Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli Nature 281 1979 646 650
16. A. Takaki, M. Wiese, and G. Maertens Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 2000 578 582
17. E. Mizukoshi, C. Eisenbach, and B.R. Edlin Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV J Infect Dis 198 2008 203 212
18. K. Kakimi, M. Isogawa, and J. Chung Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections J Virol 76 2002 8609 8620
19. T. Bauer, and W. Jilg Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination Vaccine 24 2006 572 577
20. I.J. Amanna, N.E. Carlson, and M.K. Slifka Duration of humoral immunity to common viral and vaccine antigens N Engl J Med 357 2007 1903 1915
21. B. Rehermann, C. Ferrari, and C. Pasquinelli The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat Med 2 1996 1104 1108